Variant report
Variant | nsv963773 |
---|---|
Chromosome Location | chr2:212638550-212645592 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:60)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr2:212640759-212640912 | GM12878 | blood: | n/a | n/a |
2 | BATF | chr2:212640753-212640935 | GM12878 | blood: | n/a | n/a |
3 | BCL11A | chr2:212640745-212640924 | GM12878 | blood: | n/a | n/a |
4 | BCL11A | chr2:212640762-212640953 | GM12878 | blood: | n/a | n/a |
5 | BHLHE40 | chr2:212640609-212641064 | HepG2 | liver: | n/a | n/a |
6 | CEBPB | chr2:212644451-212644746 | HepG2 | liver: | n/a | n/a |
7 | CTCF | chr2:212643515-212643549 | Kidney_OC | kidney: | n/a | n/a |
8 | CTCF | chr2:212638993-212639049 | GM13976 | blood: | n/a | n/a |
9 | CTCF | chr2:212642980-212643130 | HRE | kidney: | n/a | n/a |
10 | EBF1 | chr2:212640763-212640907 | GM12878 | blood: | n/a | n/a |
11 | ELK1 | chr2:212643645-212643687 | Hela-S3 | cervix: | n/a | n/a |
12 | EP300 | chr2:212640701-212640928 | GM12878 | blood: | n/a | n/a |
13 | EP300 | chr2:212640753-212640904 | GM12878 | blood: | n/a | n/a |
14 | FOS | chr2:212641414-212641589 | MCF10A-Er-Src | breast: | n/a | chr2:212641474-212641483 chr2:212641475-212641484 chr2:212641474-212641484 chr2:212641475-212641482 chr2:212641475-212641483 |
15 | FOSL2 | chr2:212640686-212640926 | HepG2 | liver: | n/a | n/a |
16 | FOSL2 | chr2:212640721-212640950 | HepG2 | liver: | n/a | n/a |
17 | GABPA | chr2:212640755-212640915 | Hela-S3 | cervix: | n/a | n/a |
18 | GABPA | chr2:212640754-212640886 | Hela-S3 | cervix: | n/a | n/a |
19 | GATA2 | chr2:212640749-212640960 | K562 | blood: | n/a | n/a |
20 | HEY1 | chr2:212640715-212640922 | K562 | blood: | n/a | n/a |
21 | HEY1 | chr2:212640740-212640928 | HepG2 | liver: | n/a | n/a |
22 | HEY1 | chr2:212640707-212640892 | HepG2 | liver: | n/a | n/a |
23 | JUND | chr2:212640744-212640915 | HepG2 | liver: | n/a | n/a |
24 | JUND | chr2:212640783-212640888 | HepG2 | liver: | n/a | n/a |
25 | JUND | chr2:212641318-212641650 | HepG2 | liver: | n/a | chr2:212641474-212641483 chr2:212641475-212641484 chr2:212641474-212641484 chr2:212641475-212641482 chr2:212641473-212641484 chr2:212641475-212641483 |
26 | MYC | chr2:212641083-212641141 | H1-hESC | embryonic stem cell: | n/a | n/a |
27 | PAX5 | chr2:212640713-212640958 | GM12878 | blood: | n/a | n/a |
28 | PAX5 | chr2:212640773-212640899 | GM12878 | blood: | n/a | n/a |
29 | PAX5 | chr2:212640726-212640924 | GM12878 | blood: | n/a | n/a |
30 | PAX5 | chr2:212640753-212640904 | GM12878 | blood: | n/a | n/a |
31 | PBX3 | chr2:212640783-212640886 | GM12878 | blood: | n/a | n/a |
32 | PBX3 | chr2:212640779-212640890 | GM12878 | blood: | n/a | n/a |
33 | POLR2A | chr2:212644986-212645032 | MCF-7 | breast: | n/a | n/a |
34 | POLR2A | chr2:212640753-212640918 | Hela-S3 | cervix: | n/a | n/a |
35 | POU2F2 | chr2:212640675-212640939 | GM12878 | blood: | n/a | n/a |
36 | POU2F2 | chr2:212640754-212640908 | GM12878 | blood: | n/a | n/a |
37 | RXRA | chr2:212640547-212640948 | GM12878 | blood: | n/a | n/a |
38 | SIN3AK20 | chr2:212640783-212640882 | HepG2 | liver: | n/a | n/a |
39 | SIN3AK20 | chr2:212640760-212640920 | HepG2 | liver: | n/a | n/a |
40 | SIX5 | chr2:212640738-212640934 | GM12878 | blood: | n/a | n/a |
41 | SIX5 | chr2:212640720-212640918 | K562 | blood: | n/a | n/a |
42 | SP1 | chr2:212640737-212640982 | GM12878 | blood: | n/a | n/a |
43 | SP1 | chr2:212640742-212640974 | HepG2 | liver: | n/a | n/a |
44 | SP1 | chr2:212640750-212640873 | HepG2 | liver: | n/a | n/a |
45 | SP1 | chr2:212640712-212640930 | GM12878 | blood: | n/a | n/a |
46 | SPI1 | chr2:212640771-212640919 | K562 | blood: | n/a | n/a |
47 | SPI1 | chr2:212640743-212640910 | GM12878 | blood: | n/a | n/a |
48 | STAT3 | chr2:212644508-212644605 | MCF10A-Er-Src | breast: | n/a | n/a |
49 | STAT3 | chr2:212642474-212642576 | MCF10A-Er-Src | breast: | n/a | n/a |
50 | TAF1 | chr2:212640771-212640900 | Hela-S3 | cervix: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000236007 | TF binding region |
MTND2P23 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs189769385 | chr2:212638998-212638999 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs537968783 | chr2:212639045-212639046 | Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs560262252 | chr2:212639060-212639061 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs548913528 | chr2:212639067-212639068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs373055525 | chr2:212639068-212639069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs554921405 | chr2:212639133-212639134 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs574720014 | chr2:212639152-212639153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs201415425 | chr2:212639170-212639171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs151002964 | chr2:212639176-212639177 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs140892162 | chr2:212639177-212639178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs535754986 | chr2:212640555-212640556 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs575765885 | chr2:212640572-212640573 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs555241894 | chr2:212640576-212640577 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs140479223 | chr2:212640598-212640599 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs540860886 | chr2:212640633-212640634 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs73069350 | chr2:212640660-212640661 | Inactive region | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs143662840 | chr2:212640709-212640710 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs543010671 | chr2:212640721-212640722 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs563312516 | chr2:212640729-212640730 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs552198596 | chr2:212640745-212640746 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs542488482 | chr2:212640746-212640747 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs562404068 | chr2:212640789-212640790 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs114272413 | chr2:212640790-212640791 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs548060559 | chr2:212640793-212640794 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs570444817 | chr2:212640807-212640808 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs564522892 | chr2:212640815-212640816 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs533474127 | chr2:212640816-212640817 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs73069352 | chr2:212640831-212640832 | Inactive region | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs111648725 | chr2:212640844-212640845 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs142024652 | chr2:212640852-212640853 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs548849571 | chr2:212640869-212640870 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs371636011 | chr2:212640880-212640881 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs534464919 | chr2:212640890-212640891 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs557539501 | chr2:212640894-212640895 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs577285396 | chr2:212640991-212640992 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs537172973 | chr2:212641003-212641004 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs59568831 | chr2:212641011-212641012 | Inactive region | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs144301484 | chr2:212641026-212641027 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs199500212 | chr2:212641028-212641029 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs73069355 | chr2:212641040-212641041 | Inactive region | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs72948526 | chr2:212641056-212641057 | Inactive region | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs112219013 | chr2:212641324-212641325 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs534013154 | chr2:212641346-212641347 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
44 | rs529278760 | chr2:212641364-212641365 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs375320813 | chr2:212641365-212641366 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs181062174 | chr2:212641386-212641387 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs185327761 | chr2:212641449-212641450 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs534619584 | chr2:212641452-212641453 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs55988377 | chr2:212641454-212641455 | Inactive region | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs571399287 | chr2:212641516-212641517 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cervical cancer | 21062161 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Autism | 20808228 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Non-small cell lung cancer | 18676828 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Schizophrenia | 20838587 | CNVD |
Breast cancer | 17661082 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Schizophrenia | 18990708 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:212639000-212639200 | Enhancers | Primary T helper naive cells fromperipheralblood | blood |
2 | chr2:212642400-212648400 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |